Seebri breezhaler (Glycopyrronium) is a long acting anticholinergic (LAAC) that is used to treat the symptoms of chronic obstructive pulmonary disease (COPD) such as cough, wheeze, and breathlessness. This medication works by opening the airways to make it easier to breathe. This medication is prescribed to reduce these symptoms over the long term – it is not a rescue treatment for sudden breathlessness. Glycopyrronium is taken using an inhaler device called a Breezhaler. Inhaling the medicine allows it to act directly in the lungs where it is needed most.
We currently have the brand Seebri Breezhaler from Canada manufactured by Novartis. It is available in 50 mcg inhalation powder, hard capsules.
Common side effects include:
• Dry mouth;
• Infection of the urinary tract;
• Infection of the stomach and bowel (gastroenteritis);
• Inflammation of the nose and throat, causing a runny nose and sore throat;
Seebri Breezhaler should not be used if you are allergic to any of its ingredients. Before you start treatment with this medication, inform your doctor or pharmacist about the medications you are already taking, including OTC and herbal medications. This medication should not be used by children and adolescents under 18 years of age. The capsules used in Seebri Breezhaler contain lactose. This medication should not be used by people with rare hereditary problems of galactose intolerance.